OxyContin Maker Pays New York $75,000, Tightens Marketing Of It Opioid Drugs

(August 24, 2015, 9:23 AM EDT) -- NEW YORK — OxyContin maker Purdue Pharma will pay New York state a $75,000 penalty, tighten promotion of its opioid drugs and disclose financial relationships with a pain management website under an “assurance of discontinuance,” the state Attorney General’s Office announced Aug. 20 (In the Matter of Purdue Pharma L.P., Assurance No. 15-151, N.Y. A.G.).

(Assurance of discontinuance available. Document #28-150903-005P.)

In the assurance, Purdue Pharma agrees to strengthen its Abuse and Diversion Detection program by implementing additional measures to ensure that the company and its...
To view the full article, register now.